Newswise — CLEVELAND – In honor of a transformational $10 million gift from Kimberly and Joseph Wesley, University Hospitals is establishing the Wesley Center for Immunotherapy at UH Seidman Cancer Center. This generous gift will further enable physician-scientists to engage in groundbreaking research and bring new, life-extending immunotherapy treatments to patients. One such patient is Joseph Wesley himself, who has been a patient at Seidman Cancer Center for many years.

“When a cancerous growth larger than a half dollar appeared on my cheek, I immediately went to

Dr. Teknos. Surgery and other traditional treatments weren’t options for me, so we turned to immunotherapy,” shared Joe Wesley. “Today, the growth is smaller than a dime and I will continue until I’m cancer-free. My team of doctors and nurses at UH have been tremendously helpful through the entire process. Kim and I chose to make this gift because we’re firm believers in the power of immunotherapy and want others to benefit from this leading edge innovation.”

Immunotherapy is the process of empowering a patient’s own immune system to identify and attack cancer cells. Clinical trials have shown increased rates of remission and survival as well as decreased side effects compared to conventional chemotherapy.

“Immunotherapy is an increasingly frequent component of cancer care and UH is uniquely positioned to offer it,” said Thomas F. Zenty III, UH Chief Executive Officer. “This extraordinary gift from the Wesleys will help ensure UH is able to increase our capacity to treat patients with new therapies.”

UH currently has 61 immunotherapy trials open, including 17 immunotherapy-centered clinical trials originating from the UH cell therapy facility which generates CAR-T, NK cell and other cell based therapies. In addition, UH experts are creating cells for treatment in just eight days, down from an average of 12-30 days in commercially available CAR T trials.  This innovation allows UH Seidman Cancer Center physicians to deliver therapy in a timely manner and to more patients than would otherwise be possible.  

“Of the 22 patients who have completed immunotherapy trials by receiving UH generated CAR-T cells, there’s been an overall response rate of 85 percent and a 70 percent rate of complete remission,” said Ted Teknos, MD, President and Chief Scientific Officer of UH Seidman Cancer Center. “UH is one of less than a dozen academic medical centers to have successfully manufactured CAR-T cells for human use, and is the cornerstone of the nation’s only National Center for Regenerative Medicine.”

Cancer will replace heart disease as the leading cause of death in the United States in 2020 according to the Centers for Disease Control and Prevention, and the total number of cancer cases will nearly double by 2040. UH is poised, through its leading laboratory capabilities, strong clinical trial portfolio and track record of success, to lead the way in addressing these challenges.

                                                                               ###

About University Hospitals / Cleveland, Ohio

Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 50 health centers and outpatient facilities, and 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; University Hospitals Harrington Heart & Vascular Institute, a high-volume national referral center for complex cardiovascular procedures; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is one of the largest employers in Northeast Ohio with 28,000 physicians and employees. Advancing the Science of Health and the Art of Compassion is UH’s vision for benefitting its patients into the future and To Heal. To Teach. To Discover. is the organization’s unwavering mission. Follow UH on Facebook @UniversityHospitals and Twitter @UHhospitals. For more information, visit UHhospitals.org.

About University Hospitals Seidman Cancer Center

UH Seidman Cancer Center is the only freestanding cancer hospital in Northeast Ohio, where all clinicians and staff are dedicated to the prevention, diagnosis and treatment of cancer while researching new and innovative treatment options through clinical trials. Nationally ranked cancer care is also available to patients through the 11-country region at 18 community-based locations. Our UH Seidman specialists make up 14 cancer-specific teams focused on determining integrated care plans tailored to patient’s needs. UH Seidman Cancer Center is part of the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center at Case Western Reserve University, one of 50 comprehensive cancer centers in the country. Patients have access to advanced treatment options, ranging from a pioneering stem cell transplant program founded more than 40 years ago and a wide range of immunotherapy to the first and only proton therapy center in northern Ohio for adults and children. Go to UHhospitals.org/Seidman for more information.